Key result
Mice with a desmoglein 2 mutation lacking exons 4-6 developed severe cardiac fibrosis, ventricular dilation, and cardiac insufficiency, with a significantly reduced ejection fraction (34.43% vs 67.00%, p<0.001) compared to wild-type mice.
Why the study?
Does the deletion of the extracellular adhesive domain of desmoglein 2 lead to cardiac fibrosis and ventricular dilation in mice?
Does the deletion of the extracellular adhesive domain of desmoglein 2 lead to cardiac fibrosis and ventricular dilation in mice?
Absolute Event Rate: 34.43% vs 67%
p-value: p=<0.001
Deletion of the extracellular adhesive domain of desmoglein 2 in mice causes a phenotype resembling dilative and arrhythmogenic right ventricular cardiomyopathy, characterized by cardiac fibrosis, ventricular dilation, and premature death.
Validates desmoglein-2 deletion as ARVC driver in mice; leaves open human translation and therapeutic targeting.
Desmosomes are cell-cell adhesion sites and part of the intercalated discs, which couple adjacent cardiomyocytes. The connection is formed by the extracellular domains of desmosomal cadherins that are also linked to the cytoskeleton on the cytoplasmic side. To examine the contribution of the desmosomal cadherin desmoglein 2 to cardiomyocyte adhesion and cardiac function, mutant mice were prepared lacking a part of the extracellular adhesive domain of desmoglein 2. Most live born mutant mice presented normal overall cardiac morphology at 2 weeks. Some animals, however, displayed extensive fibrotic lesions. Later on, mutants developed ventricular dilation leading to cardiac insufficiency and eventually premature death. Upon histological examination, cardiomyocyte death by calcifying necrosis and replacement by fibrous tissue were observed. Fibrotic lesions were highly proliferative in 2-week-old mutants, whereas the fibrotic lesions of older mutants showed little proliferation indicating the completion of local muscle replacement by scar tissue. Disease progression correlated with increased mRNA expression of c-myc, ANF, BNF, CTGF and GDF15, which are markers for cardiac stress, remodeling and heart failure. Taken together, the desmoglein 2-mutant mice display features of dilative cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy, an inherited human heart disease with pronounced fibrosis and ventricular arrhythmias that has been linked to mutations in desmosomal proteins including desmoglein 2.
No takes yet. Share an insight, caveat, or question.
Krusche et al. (2011) studied Arrhythmogenic right ventricular cardiomyopathy (ARVC) / Dilative cardiomyopathy (DCM) model. DSG2 mutation (lacking exons 4-6) vs. Wild-type mice (DSG2 wt/wt) was evaluated on Ejection fraction (%) (p=<0.001). Mice with a desmoglein 2 mutation lacking exons 4-6 developed severe cardiac fibrosis, ventricular dilation, and cardiac insufficiency, with a significantly reduced ejection fraction (34.43% vs 67.00%, p<0.001) compared to wild-type mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: